Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OMED | AMGN | GILD | VRTX | REGN |
| Company | Oncomed Pharma | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.93 | 337.03 | 84.39 | 477.70 | 1,149.66 |
| High | 0.93 | 338.70 | 84.65 | 482.00 | 1,165.85 |
| Low | 0.93 | 334.61 | 83.57 | 476.27 | 1,148.13 |
| Last | 0.93 | 336.13 | 84.31 | 479.35 | 1,161.62 |
| Change | +0.04 | +3.21 | +0.42 | +5.19 | +22.81 |
| % Change | +4.49% | +0.96% | +0.50% | +1.09% | +2.00% |
| Volume | 1,201 | 467,469 | 2,428,701 | 247,550 | 255,960 |
| 20-Day Average Volume | 777,535 | 1,701,354 | 6,366,860 | 950,583 | 403,008 |
| Previous Close | 0.89 | 332.92 | 83.89 | 474.16 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.02 | 329.63 | 80.08 | 480.02 | 1,166.05 |
| 20-Day Raw Stochastic | 24.44% | 88.90% | 90.62% | 51.14% | 48.58% |
| 20-Day Relative Strength | 48.64% | 58.28% | 72.06% | 50.90% | 55.12% |
| Weighted Alpha | -62.95 | +27.53 | +18.42 | +34.71 | +42.93 |
| Today's Opinion | 24% Sell | 96% Buy | 88% Buy | 56% Buy | 80% Buy |
| Previous Opinion | 40% Sell | 88% Buy | 88% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 40% Sell | 88% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.82% since 04/16/19 | +2.04% since 09/12/24 | +1.00% since 09/12/24 | +0.47% since 09/12/24 | -0.31% since 09/12/24 |
| Low | 0.82 on 04/17/19 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 1,134.59 on 09/17/24 |
| High | 1.27 on 04/17/19 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | +5.26% since 03/22/19 | +2.69% since 08/19/24 | +12.82% since 08/19/24 | -1.46% since 08/19/24 | -3.01% since 08/19/24 |
| Low | 0.82 on 04/17/19 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 |
| High | 1.27 on 04/17/19 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +27.40% since 01/23/19 | +10.06% since 06/18/24 | +33.01% since 06/18/24 | +2.92% since 06/18/24 | +11.71% since 06/18/24 |
| Low | 0.71 on 02/11/19 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 |
| High | 1.27 on 04/17/19 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -55.50% since 10/23/18 | +23.94% since 03/19/24 | +14.42% since 03/19/24 | +15.83% since 03/19/24 | +20.46% since 03/19/24 |
| Low | 0.55 on 12/26/18 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 2.14 on 10/24/18 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,434 | 178,589,936 | 104,514,608 | 122,358,416 | 125,480,912 |
| Shares Outstanding, K | 38,690 | 536,435 | 1,245,853 | 258,053 | 110,186 |
| Annual Sales | 44,420,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -8,100,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 10,180,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 3,547,100,000 |
| Last Quarter Net Income | -4,670,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 1,432,300,000 |
| 60-Month Beta | 1.86 | 0.61 | 0.18 | 0.40 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 05/14/19 | 10/29/24 | 11/05/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 29.85 |